Open AccessHigh-dose IL-2 for metastatic renal cell carcinoma: can the first antitumor immunotherapy be reinvented?
Author(s) -
Jason B. Muhitch,
Thomas Schwaab
Publication year - 2014
Publication title -
immunotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.127
H-Index - 48
eISSN - 1750-7448
pISSN - 1750-743X
DOI - 10.2217/imt.14.78
Subject(s) - renal cell carcinoma , medicine , immunotherapy , oncology , cancer , disease , clinical trial , melanoma , kidney cancer , carcinoma , cancer research